Agios Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AGIO

Comments

Agios Pharmaceuticals Inc Earnings Estimates

AGIONASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$26.53

-0.04-0.15%

At close: Feb 6, 4:00 PM EST

$26.60

0.070.26%

After Hours: Feb 6, 6:53 PM EST

Q4 2025 Earnings in 4 days from now on Thu Feb 12th, before the market open

Conference call scheduled in 4 days at 8:00 AMClick to view the webcast

Overview News

Earnings

Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Agios Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AGIO | Benzinga

Agios Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Feb 12

EPS Estimate

$-1.960

Quarterly Revenue Estimate

$11.35M

Annual Revenue
(as of Sep 30)

$44.79M

Analyze the earnings history of Agios Pharmaceuticals using advanced sorting and filters.

Agios Pharmaceuticals (AGIO) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %

Q3	2025-10-30	$-1.78	$-1.92	7.29 %
Q2	2025-07-31	$-1.93	$-1.77	-9.04 %
Q1	2025-05-01	$-1.55	$-1.76	11.9 %
Q4	2025-02-13	$-1.94	$-1.63	-19.0 %

Agios Pharmaceuticals (AGIO) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %

Q3	2025-10-30	$12.88M	$10.40M	23.8 %
Q2	2025-07-31	$12.46M	$9.36M	33.1 %
Q1	2025-05-01	$8.73M	$9.68M	-9.86 %
Q4	2025-02-13	$10.70M	$9.35M	14.4 %

FAQ

When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?

Agios Pharmaceuticals (AGIO) is scheduled to report earnings on April 30, 2026. The last reported earnings were for reported on October 30, 2025 for Q3.

What were the latest earnings per share (EPS) for Agios Pharmaceuticals (NASDAQ:AGIO)?

The Actual EPS was $-1.78, which beat the estimate of $-1.92.

What were Agios Pharmaceuticals’s (NASDAQ:AGIO) revenues?

The Actual Revenue was $12.88M, which beat the estimate of $10.40M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch

Tango Therapeutics Inc

Sionna Therapeutics Inc

Monte Rosa Therapeutics Inc

NASDAQ:GLUE

$19.55

Relay Therapeutics Inc

NASDAQ:RLAY

$9.02

1.12%